•
Dec 31, 2021

Albemarle Q4 2021 Earnings Report

Albemarle reported a net loss but adjusted EPS exceeded expectations, driven by strong performance in Lithium and Bromine businesses.

Key Takeaways

Albemarle Corporation reported Q4 2021 results with net sales increasing by 2% to $894 million. The company experienced a net loss of $3.8 million, but adjusted EBITDA increased by 3% to $229 million. The company is raising its 2022 outlook based on favorable market conditions.

Net sales increased by 2% to $894 million.

Net loss was ($3.8) million, or ($0.03) per diluted share; Adjusted diluted EPS was $1.01.

Adjusted EBITDA increased by 3% to $229 million.

Full year 2022 outlook improved, expecting adjusted EBITDA to be 35%-55% higher Y/Y excluding FCS.

Total Revenue
$894M
Previous year: $879M
+1.7%
EPS
$1.01
Previous year: $1.17
-13.7%
Adjusted EBITDA
$229M
Previous year: $221M
+3.5%
Gross Profit
$237M
Previous year: $265M
-10.9%
Cash and Equivalents
$439M
Previous year: $747M
-41.2%
Free Cash Flow
-$447M
Previous year: $108M
-513.8%
Total Assets
$11B
Previous year: $10.5B
+5.0%

Albemarle

Albemarle

Albemarle Revenue by Segment

Forward Guidance

Albemarle expects that its full year 2022 results across all business units will improve relative to full year 2021. Capital expenditures are anticipated to be higher than previously planned as the company invests to accelerate conversion capacity additions and meet evolving industry standards, as well as continued inflationary pressures.

Revenue & Expenses

Visualization of income flow from segment revenue to net income